How to Buy Virax Biolabs Group Stock
Virax Biolabs Group Ltd
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.
Virax Biolabs Group stock last closed at $0.91, down 8.15% from the previous day, and has increased 29.5% in one year. It has overperformed other stocks in the Biotechnology industry by 1.07 percentage points. Virax Biolabs Group stock is currently +52.17% from its 52-week low of $0.60, and -89.86% from its 52-week high of $9.00.
There are currently 4.34M VRAX shares outstanding. The market capitalization of VRAX is $3.96M. In the past 24 hours, 38,198 VRAX shares were traded.
How to Buy Virax Biolabs Group Stock
Not sure how to invest in Virax Biolabs Group stock? Here's how.
- Decide where to buy Virax Biolabs Group stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Virax Biolabs Group stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Choose your payment method and add your details.
- Evaluate Virax Biolabs Group stock: The Virax Biolabs Group ticker symbol is VRAX. Is Virax Biolabs Group stock a good investment? Should you buy shares of VRAX? How do VRAX's underlying business fundamentals look? Do top analysts think Virax Biolabs Group is a good buy? Why has VRAX's stock price moved recently? (Hint: Our stock research website can help you decide if VRAX is a good stock to buy).
- Execute your VRAX buy order: Decide if you will purchase VRAX shares at the current market price or use a limit order to buy VRAX shares at a particular price.
- Keep an eye on your VRAX position: Create a watchlist to get the latest news on your investment in Virax Biolabs Group stock.
Step 1: Decide where to buy Virax Biolabs Group stock
You will need a brokerage account in order to access the NASDAQ market and buy VRAX stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal info so you are able to invest in VRAX stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start your new brokerage account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have created your account on the best stock app for beginners, your next step is to transfer the money for your investment:
Check out this video walkthrough if you need help depositing funds into your investment account.
Step 4: Evaluate Virax Biolabs Group stock
After you have chosen the best place to buy Virax Biolabs Group stock, it's important to research their stock before you buy, so you can wrap your head around the risk as well as the opportunity.
Virax Biolabs Group Numbers
VRAX Overview
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on VRAX's stock page.
Is VRAX stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge VRAX's fair value.
Using relative valuations ratios:
- VRAX may be undervalued based on its P/B ratio of 0.46x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation research on VRAX's stock here.
A quick look at VRAX Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the VRAX balance sheet.
- VRAX has cash burn of 5412240. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the VRAX balance sheet.
- VRAX has a low debt to equity ratio of 0.12.
Failed Financial Due Diligence Checks:
- VRAX has $7.29M in cash and short term investments. This is not enough to cover its annual cash burn of $5.41M.
- VRAX profit margin has gone up by 9.78 percentage points in the past year, but the company is still unprofitable.
Do Wall Street analysts think it's a good time to buy VRAX stock
Out of 1 Wall Street analysts who give forecasts on VRAX, the consensus analyst rating on VRAX is a Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Virax Biolabs Group stock forecast page.
VRAX Trading Indicators
How is VRAX performing as a company?
Last year, VRAX revenue was $84.87k. In the past three year, VRAX's revenue has grown by -61.02% per year. This was slower than the Biotechnology industry average of 44.31%.
You can research VRAX's earnings and revenue performance here.
What are VRAX insiders up to?
In the past year, executives and large shareholders at VRAX have not bought or sold any shares.
Research more about who owns VRAX stock here.
Can I get consistent income from VRAX stock?
No, Virax Biolabs Group doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your VRAX buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount, place a limit order.
Hit the Open Trade button and eToro will execute your order.
If you require additional assistance buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your VRAX position
Now that you own some VRAX shares, you'll want to keep up with your new investment.
Add VRAX to a watchlist to get the latest updates about your VRAX stock.
VRAX Feed
How to Buy Stock in Virax Biolabs Group
To summarize, here are the 6 steps you need to take to buy Virax Biolabs Group stock right now:
- Decide where to buy Virax Biolabs Group stock
- Open your brokerage account
- Put funds into your brokerage account
- Evaluate Virax Biolabs Group stock
- Execute your VRAX buy order
- Keep an eye on your VRAX position
If you need a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Virax Biolabs Group, create a watchlist on WallStreetZen today.
More Content You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.